On September 22, BIREN TECH rose 4.42% in regular trading, trading at HK$43.42/share with turnover of HK$67.76 million, extending the previous session's surge of over 12%.
On the news front, the rally is underpinned by a confluence of positive catalysts. The company has officially denied market rumors of a US$1 billion share placement, alleviating dilution concerns. Meanwhile, multiple institutions have issued or reiterated buy ratings in recent sessions. Goldman Sachs maintained its buy rating with a target price of HK$80.5, citing continued AI chip shipment ramp-up. Daiwa reiterated its buy rating, expressing confidence in the next-generation flagship BR20x chip, which is in final parameter tuning and verification ahead of cloud service provider testing. Guojin Securities initiated coverage with a buy rating, noting the company is transitioning from product validation to scaled commercialization.
On the fundamentals side, H1 revenue reached RMB 1.236 billion, surging approximately 20 times year-over-year, while gross margin improved to 42.7% and adjusted net loss narrowed 38.9%. Morgan Stanley recently increased its stake to 5.02%, signaling institutional confidence. Analysts broadly expect the company to achieve breakeven by next year as operating leverage continues to improve.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments